> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Arthrosurface Shoulder Device Cleared by FDA
- URL: https://www.fdaweb.com/arthrosurface-shoulder-device-cleared-by-fda/
- Published: 2018-04-19T12:00:00.000Z
- Updated: 2026-09-14T23:59:55.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5141263

FDA has cleared an Arthrosurface 510(k) to market the stemless OVOMotion Shoulder Arthroplasty System that the company says is intended to provide surgeons with an approach that results in increased exposure to the glenoid, minimizes bone removal, and is designed for patients with painful or severely disabled shoulder joints resulting from arthritis or traumatic events. The device is cleared for use in conjunction with the Arthrosurface Inlay Glenoid System, according to the company. “The OVOMotion Shoulder Arthroplasty System is intended to be the first of a three-element modular stemless system that will ultimately allow surgeons to intra-operatively choose between stemless, traditional and reverse options,” it says.